Manufacturing licence negotiations for gene therapies for orphan diseases Challenge A private biotech company developing gene therapy products for several orphan diseases was in the process of initiating CMC development for their pipeline products. In order to move forward, they needed to acquire commercial manufacturing licenses for several technologies that would be required for the production of their therapeutic products, including cell lines and patented processes for AAV manufacturing. The client had identified institutions and companies that owned the IP they required, but given their small business development team, they did not have the bandwidth to conduct the negotiations required to secure the licenses. The company sought interim support from Alacrita to secure the manufacturin

Join for free to read